| Human neutralizing antibodies elicited by SARS-CoV-2 infection B Ju, Q Zhang, J Ge, R Wang, J Sun, X Ge, J Yu, S Shan, B Zhou, S Song, ... Nature 584 (7819), 115-119, 2020 | 1785 | 2020 |
| Antibody neutralization of SARS-CoV-2 through ACE2 receptor mimicry J Ge, R Wang, B Ju, Q Zhang, J Sun, P Chen, S Zhang, Y Tian, S Shan, ... Nature communications 12 (1), 250, 2021 | 129 | 2021 |
| Potent and protective IGHV3-53/3-66 public antibodies and their shared escape mutant on the spike of SARS-CoV-2 Q Zhang, B Ju, J Ge, JFW Chan, L Cheng, R Wang, W Huang, M Fang, ... Nature communications 12 (1), 4210, 2021 | 92 | 2021 |
| Key gp120 glycans pose roadblocks to the rapid development of VRC01-class antibodies in an HIV-1-infected Chinese donor L Kong, B Ju, Y Chen, L He, L Ren, J Liu, K Hong, B Su, Z Wang, ... Immunity 44 (4), 939-950, 2016 | 86 | 2016 |
| Structural basis for bivalent binding and inhibition of SARS-CoV-2 infection by human potent neutralizing antibodies R Yan, R Wang, B Ju, J Yu, Y Zhang, N Liu, J Wang, Q Zhang, P Chen, ... Cell research 31 (5), 517-525, 2021 | 55 | 2021 |
| Impact of the N501Y substitution of SARS-CoV-2 Spike on neutralizing monoclonal antibodies targeting diverse epitopes L Cheng, S Song, B Zhou, X Ge, J Yu, M Zhang, B Ju, Z Zhang Virology journal 18 (1), 1-6, 2021 | 31 | 2021 |
| Antigenic sin of wild-type SARS-CoV-2 vaccine shapes poor cross-neutralization of BA. 4/5/2.75 subvariants in BA. 2 breakthrough infections B Ju, Q Fan, M Wang, X Liao, H Guo, H Wang, X Ge, L Liu, Z Zhang Nature Communications 13 (1), 7120, 2022 | 26 | 2022 |
| Immune escape by SARS-CoV-2 Omicron variant and structural basis of its effective neutralization by a broad neutralizing human antibody VacW-209 B Ju, Q Zheng, H Guo, Q Fan, T Li, S Song, H Sun, S Shen, X Zhou, ... Cell research 32 (5), 491-494, 2022 | 21 | 2022 |
| A VH1-69 antibody lineage from an infected Chinese donor potently neutralizes HIV-1 by targeting the V3 glycan supersite S Kumar, B Ju, B Shapero, X Lin, L Ren, L Zhang, D Li, Z Zhou, Y Feng, ... Science Advances 6 (38), eabb1328, 2020 | 18 | 2020 |
| Sequential immunization with SARS-CoV-2 RBD vaccine induces potent and broad neutralization against variants in mice S Song, B Zhou, L Cheng, W Liu, Q Fan, X Ge, H Peng, YX Fu, B Ju, ... Virology Journal 19 (1), 1-5, 2022 | 17 | 2022 |
| Cross-neutralization of SARS-CoV-2 Kappa and Delta variants by inactivated vaccine-elicited serum and monoclonal antibodies L Cheng, S Song, Q Fan, S Shen, H Wang, B Zhou, X Ge, B Ju, Z Zhang Cell Discovery 7 (1), 112, 2021 | 17 | 2021 |
| Potent antibody immunity to SARS‐CoV‐2 variants elicited by a third dose of inactivated vaccine B Ju, B Zhou, S Song, Q Fan, X Ge, H Wang, L Cheng, H Guo, D Shu, ... Clinical and translational medicine 12 (2), 2022 | 16 | 2022 |
| Increased resistance of SARS-CoV-2 Lambda variant to antibody neutralization H Guo, Q Fan, S Song, S Shen, B Zhou, H Wang, L Cheng, X Ge, B Ju, ... Journal of Clinical Virology 150, 105162, 2022 | 12 | 2022 |
| Interleukin-21 administration leads to enhanced antigen-specific T cell responses and natural killer cells in HIV-1 vaccinated mice B Ju, D Li, X Ji, J Liu, H Peng, S Wang, Y Liu, Y Hao, C Yee, H Liang, ... Cellular immunology 303, 55-65, 2016 | 12 | 2016 |
| Omicron variants escape the persistent SARS-CoV-2-specific antibody response in 2-year COVID-19 convalescents regardless of vaccination M Wang, B Zhou, Q Fan, X Zhou, X Liao, J Lin, Z Ma, J Dong, H Wang, ... Emerging Microbes & Infections 12 (1), 2151381, 2023 | 10 | 2023 |
| The SARS-CoV-2 inactivated vaccine enhances the broad neutralization against variants in individuals recovered from COVID-19 up to one year X Zhou, L Cheng, H Wang, X Liao, M Wang, L Wei, S Song, B Zhou, Z Ma, ... Emerging Microbes & Infections 11 (1), 753-756, 2022 | 8 | 2022 |
| Identification of a novel broadly HIV-1-neutralizing antibody from a CRF01_AE-infected Chinese donor B Ju, D Li, L Ren, J Hou, Y Hao, H Liang, S Wang, J Zhu, M Wei, Y Shao Emerging Microbes & Infections 7 (1), 1-12, 2018 | 8 | 2018 |
| Identification and application of a pair of noncompeting monoclonal antibodies broadly binding to the nucleocapsid proteins of SARS-CoV-2 variants including Omicron B Zhou, L Cheng, S Song, H Guo, S Shen, H Wang, X Ge, L Liu, B Ju, ... Virology Journal 19 (1), 96, 2022 | 7 | 2022 |
| A fourth dose of Omicron RBD vaccine enhances broad neutralization against SARS‐CoV‐2 variants including BA. 1 and BA. 2 in vaccinated mice B Zhou, S Song, H Guo, X Zhou, Q Fan, W Liu, L Cheng, X Ge, B Ju, ... Journal of Medical Virology 94 (8), 3992-3997, 2022 | 5 | 2022 |
| Structural and functional analysis of an inter-Spike bivalent neutralizing antibody against SARS-CoV-2 variants Y Li, Q Fan, B Zhou, Y Shen, Y Zhang, L Cheng, F Qi, S Song, Y Guo, ... Iscience 25 (6), 104431, 2022 | 4 | 2022 |
